← Eichor
Study identifier: NCT07290140 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis

Condition: Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps  ·  Sponsor: Airiver Medical, Inc.

PhaseNA
Planned participants300
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is a prospective, multicenter, randomized, controlled, double-blind clinical trial enrolling 300 adult subjects with chronic rhinosinusitis (CRS) with and without nasal polyps (CRSwNP and CRSsNP) indicated for endoscopic sinus surgery (ESS).

This description comes directly from the study's public registry record.

Talk to the study team

Sr Clinical Operation Director  ·  6123250226  ·  myersj@airiver.com

Chief Operation Officer  ·  vajgrtp@airiver.com

Always discuss trial participation with your own doctor first.

Locations (8)

Excel ENTBirmingham, Alabama, United StatesRecruiting
SENTA ClinicaSan Diego, California, United StatesRecruiting
Colorado ENT & AllergyColorado Springs, Colorado, United StatesRecruiting
Physicians' Clinic of IowaCedar Rapids, Iowa, United StatesRecruiting
Advanced ENTLouisville, Kentucky, United StatesRecruiting
University of PennsylvaniaPhiladelphia, Pennsylvania, United StatesRecruiting
Dallas ENTDallas, Texas, United StatesRecruiting
University of VirginiaCharlottesville, Virginia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07290140